Page last updated: 2024-12-07

spiroxamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

spiroxamine: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

spiroxamine : The spiroketal resulting from the formal condensation of 4-tert-butylcyclohexanone with 3-[ethyl(propyl)amino]propane-1,2-diol. An inhibitor of ergosterol synthesis, it is a broad spectrum agricultural fungicide used particularly against powdery mildew in the production of cereals, bananas and grapes. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID86160
CHEMBL ID445338
CHEBI ID9242
SCHEMBL ID20282
MeSH IDM0498798

Synonyms (48)

Synonym
kwg4168
118134-30-8
spiroxamine
NCGC00164315-01
spiroxamine [iso]
n-[(8-tert-butyl-1,4-dioxaspiro[4.5]dec-2-yl)methyl]-n-ethylpropan-1-amine
NCGC00164315-02
(8-tert-butyl-1,4-dioxa-spiro[4.5]dec-2-ylmethyl)-ethyl-propyl-amine
8-(1,1-dimethylethyl)-n-ethyl-n-propyl-1,4-dioxaspiro(4.5)decane-2-methanamine
impulse
CHEBI:9242 ,
CHEMBL445338
FT-0655721
n-[(8-tert-butyl-1,4-dioxaspiro[4.5]decan-3-yl)methyl]-n-ethylpropan-1-amine
n-[(8-tert-butyl-1,4-dioxaspiro[4.5]decan-3-yl)methyl]-n-ethyl-propan-1-amine
A803888
NCGC00164315-03
1,4-dioxaspiro(4.5)decane-2-methanamine, 8-(1,1-dimethylethyl)-n-ethyl-n-propyl-
8-tert-butyl-1,4-dioxaspiro(4.5)decan-2-ylmethyl(ethyl)(propyl)amine
unii-out5yhb7bo
out5yhb7bo ,
NCGC00255061-01
dtxcid9014212
dtxsid1034212 ,
cas-118134-30-8
tox21_301163
n-((8-(tert-butyl)-1,4-dioxaspiro[4.5]decan-2-yl)methyl)-n-ethylpropan-1-amine
AKOS015895921
spiroxamine [mi]
spiroketalamine
kwg-4168
SCHEMBL20282
J-504005
1,4-dioxaspiro[4.5]decane-2-methanamine,8-(1,1-dimethylethyl)-n-ethyl-n-propyl-
c18h35no2
spiroxamine-2
PUYXTUJWRLOUCW-UHFFFAOYSA-N
spiroxamine-1
n-ethyl-n-propyl-8-tert-butyl-1,4-dioxaspiro[4.5]dec-2-ylmethylamine
mfcd03095708
spiroxamine, pestanal(r), analytical standard
spiroxamine 10 microg/ml in acetonitrile
piroxamine
spiroxamine isomer i
spiroxamine isomer ii
Q1850388
n-[(8-tert-butyl-1,4-dioxaspiro[4.5]dec-2-yl)methyl]-n-ethylpropan-1-amin
F87643

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" Excessive pesticide levels in soil can exert negative effects on soil-dwelling organisms by decreasing their bioavailability and, consequently, lowering soil quality."( Microbiological and biochemical properties of soil polluted with a mixture of spiroxamine, tebuconazole, and triadimenol under the cultivation of Triticum aestivum L.
Baćmaga, M; Kucharski, J; Wyszkowska, J, 2019
)
0.74
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
sterol biosynthesis inhibitorAny compound that inhibits the biosynthesis of any sterol.
xenobioticA xenobiotic (Greek, xenos "foreign"; bios "life") is a compound that is foreign to a living organism. Principal xenobiotics include: drugs, carcinogens and various compounds that have been introduced into the environment by artificial means.
environmental contaminantAny minor or unwanted substance introduced into the environment that can have undesired effects.
antifungal agrochemicalAny substance used in acriculture, horticulture, forestry, etc. for its fungicidal properties.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
dioxolane
tertiary amino compoundA compound formally derived from ammonia by replacing three hydrogen atoms by organyl groups.
spiroketalA cyclic ketal in which the ketal carbon is the only common atom of two rings.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (8)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
hypoxia-inducible factor 1 alpha subunitHomo sapiens (human)Potency0.19493.189029.884159.4836AID1224846
AR proteinHomo sapiens (human)Potency0.01260.000221.22318,912.5098AID588516
farnesoid X nuclear receptorHomo sapiens (human)Potency0.00890.375827.485161.6524AID588527
estrogen nuclear receptor alphaHomo sapiens (human)Potency1.38010.000229.305416,493.5996AID743075
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency61.644819.739145.978464.9432AID1159509
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency8.91250.010039.53711,122.0200AID588547
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency52.58600.000323.4451159.6830AID743065; AID743067
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency68.58960.000627.21521,122.0200AID743202
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID386135Antifungal activity against Aspergillus niger JvD1.1 at 104.2 ug/mL by microtiter plate2007The Journal of biological chemistry, Nov-09, Volume: 282, Issue:45
Survival in the presence of antifungals: genome-wide expression profiling of Aspergillus niger in response to sublethal concentrations of caspofungin and fenpropimorph.
AID386134Induction of GFP tagged PagsA-H2B expression in Aspergillus niger RD6.47 at 104.2 ug/mL by fluorescence microscopy2007The Journal of biological chemistry, Nov-09, Volume: 282, Issue:45
Survival in the presence of antifungals: genome-wide expression profiling of Aspergillus niger in response to sublethal concentrations of caspofungin and fenpropimorph.
AID386136Antifungal activity against Aspergillus niger RD6.47 at 104.2 ug/mL by microtiter plate2007The Journal of biological chemistry, Nov-09, Volume: 282, Issue:45
Survival in the presence of antifungals: genome-wide expression profiling of Aspergillus niger in response to sublethal concentrations of caspofungin and fenpropimorph.
AID386133Induction of GFP tagged PagsA expression in Aspergillus niger JvD1.1 at 104.2 ug/mL by fluorescence microscopy2007The Journal of biological chemistry, Nov-09, Volume: 282, Issue:45
Survival in the presence of antifungals: genome-wide expression profiling of Aspergillus niger in response to sublethal concentrations of caspofungin and fenpropimorph.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (42.86)29.6817
2010's6 (42.86)24.3611
2020's2 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 38.85

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index38.85 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.57 (4.65)
Search Engine Demand Index59.45 (26.88)
Search Engine Supply Index2.32 (0.95)

This Compound (38.85)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]